Bone morphogenic proteins are overexpressed in malignant melanoma and promote cell invasion and migration

Cancer Research

Volumn 65, Issue 2, 2005, Pages 448-456

  Rothhammer, Tanja ^a   Poser, Ina ^a   Soncin, Fabrice ^b   Bataille, Frauke ^a   Moser, Markus ^c   Bosserhoff, Anja Katrin ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b INSTITUT DE BIOLOGIE DE LILLE   (France)

^c MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; CHORDIN; OSTEOGENIC PROTEIN 1; TRANSCRIPTION FACTOR ETS 1;

ARTICLE; CANCER GROWTH; CANCER INVASION; CELL CLONE; CELL INVASION; CELL MIGRATION; GENE OVEREXPRESSION; IMMUNOHISTOCHEMISTRY; MELANOMA; MELANOMA CELL; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ANIMALS; BASE SEQUENCE; BONE MORPHOGENETIC PROTEINS; CELL LINE, TUMOR; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MELANOMA; MELANOMA, EXPERIMENTAL; MICE; MOLECULAR SEQUENCE DATA; NEOPLASM INVASIVENESS; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEIN C-ETS-1; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-ETS; TRANSCRIPTION FACTOR AP-2; TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 12544259720     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Hogan BL. Bone morphogenetic proteins in development. Curr Opin Genet Dev 1996;6:432-8.
2. Miyazawa K, Shinozaki M, Hara T, Furuya T, Miyazono K. Two major Smad pathways in TGF-β superfamily signalling. Genes Cells 2002;7:1191-204.
3. Teicher BA. Malignant cells, directors of the malignant process: role of transforming growth factor-β. Cancer Metastasis Rev 2001;20:133-43.
4. Gold LI. The role for transforming growth factor-β (TGF-β) in human cancer. Crit Rev Oncog 1999;10:303-60.
5. Albino AP, Davis BM, Nanus DM. Induction of growth factor RNA expression in human malignant melanoma: markers of transformation. Cancer Res 1991;51:4815-20.
6. Reed JA, McNutt NS, Prieto VG, Albino AP. Expression of transforming growth factor-β2 in malignant melanoma correlates with the depth of tumor invasion. Implications for tumor progression. Am J Pathol 1994;145:97-104.
7. Van Belle P, Rodeck U, Nuamah I, Halpern AC, Elder DE. Melanoma-associated expression of transforming growth factor-β isoforms. Am J Pathol 1996;148:1887-94.
8. Schmid P, Itin P, Rufli T. In situ analysis of transforming growth factor-βs (TGF-β1, TGF-β2, TGF-β3), and TGF-β type II receptor expression in malignant melanoma. Carcinogenesis 1995;16:1499-503.
9. Gobbi G, Sangiorgi L, Lenzi L, et al. Seven BMPs and all their receptors are simultaneously expressed in osteosarcoma cells. Int J Oncol 2002;20:143-7.
10. Hatakeyama S, Ohara-Nemoto Y, Kyakumoto S, Satoh M. Expression of bone morphogenetic protein in human adenocarcinoma cell line. Biochem Biophys Res Commun 1993;190:695-701.
11. Ide H, Yoshida T, Matsumoto N, et al. Growth regulation of human prostate cancer cells by bone morphogenetic protein-2. Cancer Res 1997;57:5022-27.
12. Kleeff J, Maruyama H, Ishiwata T, et al. Bone morphogenetic protein 2 exerts diverse effects on cell growth in vitro and is expressed in human pancreatic cancer in vivo. Gastroenterology 1999;116:1202-16.
13. Jacob K, Wach F, Holzapfel U et al. In vitro modulation of human melanoma cell invasion and proliferation by all-trans-retinoic acid. Melanoma Res 1998;8:211-9.
14. Petzoldt JL, Leigh IM, Duffy PG, Sexton C, Masters JR. Immortalisation of human urothelial cells. Urol Res 1995;23:377-80.
15. Rothhammer T, Hahne JC, Florin A, et al. The Ets-1 transcription factor is involved in the development and invasion of malignant melanoma. Cell Mol Life Sci 2004;61:118-28.
16. Poser I, Dominguez D, de Herreros AG, et al. Loss of E-cadherin expression in melanoma cells involves up-regulation of the transcriptional repressor snail. J Biol Chem 2001;276:24661-6.
17. Tellez C, McCarty M, Ruiz M, Bar-Eli M. Loss of activator protein-2α results in overexpression of protease-activated receptor-1 and correlates with the malignant phenotype of human melanoma J Biol Chem 2003;278:46632-42.
18. Karjalainen JM, Kellokoski JK, Eskelinen MJ, Alhava EM, Kosma VM. Downregulation of transcription factor AP-2 predicts poor survival in stage I cutaneous malignant melanoma. J Clin Oncol 1998;16:3584-91.
19. Huang S, Jean D, Luca M, Tainsky MA, Bar-Eli M. Loss of AP-2 results in downregulation of c-KIT and enhancement of melanoma tumorigenicity and metastasis. EMBO J 1998;17:4358-69.
20. Piccolo S, Sasai Y, Lu B, De Robertis EM. Dorsoventral patterning in Xenopus: inhibition of ventral signals by direct binding of chordin to BMP-4. Cell 1996;86:589-98.
21. Millet C, Lemaire P, Orsetti B, Guglielmi P, Francois V. The human chordin gene encodes several differentially expressed spliced variants with distinct BMP opposing activities. Mech Dev 2001;106:85-96.
22. Kiyozuka Y, Nakagawa H, Senzaki H, et al. Bone morphogenetic protein-2 and type IV collagen expression in psammoma body forming ovarian cancer. Anticancer Res 2001;21:1723-30.
23. Hatakeyama S, Gao YH, Ohara-Nemoto Y, Kataoka H, Satoh M. Expression of bone morphogenetic proteins of human neoplastic epithelial cells. Biochem Mol Biol Int 1997;42:497-505.
24. Sulzbacher I, Birner P, Trieb K, Pichlbauer E, Lang S. The expression of bone morphogenetic proteins in osteosarcoma and its relevance as a prognostic parameter. J Clin Pathol 2002;55:381-5.
25. Grcevic D, Marusic A, Grahovac B, Jaksic B, Kusec R. Expression of bone morphogenetic proteins in acute promyelocytic leukemia before and after combined all trans-retinoic acid and cytotoxic treatment. Leuk Res 2003;27:731-8.
26. Ebara S, Kawasaki S, Nakamura I, et al. Transcriptional regulation of the mBMP-4 gene through an E-box in the 5′-flanking promoter region involving USF. Biochem Biophys Res Commun 1997;240:136-41.
27. Shore EM, Xu M, Shah PB, et al. The human bone morphogenetic protein 4 (BMP-4) gene: molecular structure and transcriptional regulation. Calcif Tissue Int 1998;63:221-9.
28. Nyormoi O, Bar-Eli M. Transcriptional regulation of metastasis-related genes in human melanoma. Clin Exp Metastasis 2003;20:251-63.
29. Willette RN, Gu JL, Lysko PG, et al. BMP-2 gene expression and effects on human vascular smooth muscle cells. J Vasc Res 1999;36:120-5.
30. Cunningham NS, Paralkar V, Reddi AH. Osteogenin and recombinant bone morphogenetic protein 2B are chemotactic for human monocytes and stimulate transforming growth factor β1 mRNA expression. Proc Natl Acad Sci U S A 1992;89:11740-4.
31. Fiedler J, Roderer G, Gunther KP, Brenner RE. BMP-2, BMP-4, and PDGF-bb stimulate chemotactic migration of primary human mesenchymal progenitor cells. J Cell Biochem 2002;87:305-12.
32. King GN, Hughes FJ. Bone morphogenetic protein-2 stimulates cell recruitment and cementogenesis during early wound healing. J Clin Periodontol 2001;28:465-75.
33. Dorsky RJ, Moon RT, Raible DW. Environmental signals and cell fate specification in premigratory neural crest. BioEssays 2000;22:708-16.
34. Langenfeld EM, Calvano SE, Abou-Nukta F, et al. The mature bone morphogenetic protein-2 is aberrantly expressed in non-small cell lung carcinomas and stimulates tumor growth of A549 cells. Carcinogenesis 2003;24:1445-54.
35. Hjertner O, Hjorth-Hansen H, Borset M, et al. Bone morphogenetic protein-4 inhibits proliferation and induces apoptosis of multiple myeloma cells. Blood 2001;97:516-22.
36. Andrews PW, Damjanov I, Berends J, et al. Inhibition of proliferation and induction of differentiation of pluripotent human embryonal carcinoma cells by osteogenic protein-1 (or bone morphogenetic protein-7). Lab Invest 1994;71:243-51.
37. Hoffman MP, Kidder BL, Steinberg ZL, et al. Gene expression profiles of mouse submandibular gland development: FGFR1 regulates branching morphogenesis in vitro through BMP- and FGF-dependent mechanisms. Development 2002;129:5767-78.
38. Dell'Era P, Ronca R, Coco L, et al. Fibroblast growth factor receptor-1 is essential for in vitro cardiomyocyte development. Circ Res 2003;93:414-20.
39. Hyatt BA, Shangguan X, Shannon JM. BMP4 modulates fibroblast growth factor-mediated induction of proximal and distal lung differentiation in mouse embryonic tracheal epithelium in mesenchyme-free culture. Dev Dyn 2002;225:153-65.
40. Lillien L, Raphael H. BMP and FGF regulate the development of EGF-responsive neural progenitor cells. Development 2000;127:4993-5005.
41. Ericson J, Norlin S, Jessell TM, Edlund T. Integrated FGF and BMP signaling controls the progression of progenitor cell differentiation and the emergence of pattern in the embryonic anterior pituitary. Development 1998;125:1005-15.
42. Xerri L, Battyani Z, Grob JJ, et al. Expression of FGF1 and FGFR1 in human melanoma tissues. Melanoma Res 1996;6:223-30.
43. Shan S, Robson ND, Cao Y, et al. Responses of vascular endothelial cells to angiogenic signaling are important for tumor cell survival. FASEB J 2004;18:326-8.
44. Nesbit M, Nesbit HK, Bennett J, et al. Basic fibroblast growth factor induces a transformed phenotype in normal human melanocytes. Oncogene 1999;18:6469-76.
45. Meier F, Caroli U, Satyamoorthy K, et al. Fibroblast growth factor-2 but not MeI-CAM and/or β3 integrin promotes progression of melanocytes to melanoma. Exp Dermatol 2003;12:296-306.
46. Yayon A, Ma YS, Safran M, Klagsbrun M, Halaban R. Suppression of autocrine cell proliferation and tumorigenesis of human melanoma cells and fibroblast growth factor transformed fibroblasts by a kinase-deficient FGF receptor 1: evidence for the involvement of Src-family kinases. Oncogene 1997;14:2999-3009.
47. Wang Y, Becker D. Antisense targeting of basic fibroblast growth factor and fibroblast growth factor receptor-1 in human melanomas blocks intratumoral angiogenesis and tumor growth. Nat Med 1997;3:887-93.
48. Becker D, Lee PL, Rodeck U, Herlyn M. Inhibition of the fibroblast growth factor receptor 1 (FGFR-1) gene in human melanocytes and malignant melanomas leads to inhibition of proliferation and signs indicative of differentiation. Oncogene 1992;7:2303-13.